Covista (CVSA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for November 12, 2025, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by November 11, 2025, or November 9, 2025, for plan-held shares.
Voting matters and shareholder proposals
Election of ten directors is on the agenda, with all nominees recommended by the board.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year ending June 30, 2026.
Advisory vote on executive compensation (say-on-pay) is included.
Provision to transact other business as may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Ten director nominees listed for election, including Stephen W. Beard, William W. Burke, Donna J. Hrinak, Georgette Kiser, Liam Krehbiel, Michael W. Malafronte, Sharon L. O'Keefe, Kenneth J. Phelan, Betty Vandenbosch, and Lisa W. Wardell.
Latest events from Covista
- AI-driven growth and operational excellence target 120,000+ students and double-digit EPS by FY29.CVSA
Investor Day 202625 Feb 2026 - Raised EPS guidance, strong enrollment, and $750M buyback drive robust financial results.CVSA
Q2 20263 Feb 2026 - Double-digit enrollment and earnings growth in FY24, with robust FY25 outlook.CVSA
Q4 20242 Feb 2026 - Record enrollment and margin gains highlight leadership in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Double-digit revenue and enrollment growth led to higher earnings and raised FY25 guidance.CVSA
Q1 202518 Jan 2026 - Double-digit growth in revenue, enrollment, and EPS, with raised 2025 guidance and lower leverage.CVSA
Q2 20259 Jan 2026 - Record financial and academic results, with strong governance and pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - FY2024 saw record growth, strong diversity, and robust pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - Record FY25 growth and strong FY26 outlook, driven by enrollment and partnerships.CVSA
Q4 202523 Nov 2025